Results 151 to 160 of about 30,536 (239)

Ipilimumab plus decitabine for patients with MDS or AML in post-transplant or transplant naïve settings.

Blood, 2022
Jacqueline S. Garcia, Yael Flamand, L. Penter, M. Keng, B. Tomlinson, L. Mendez, Paul B. Koller, Nicole Cullen, Y. Arihara, Kathleen L. Pfaff, J. Wolff, A. Brunner, I. Galinsky, A. Bashey, J. Antin, C. Cutler, V. Ho, B. Jonas, M. Luskin, M. Wadleigh, E. Winer, A. Savell, Rebecca Leonard, Taylor Robertson, M. Davids, H. Streicher, S. Rodig, J. Ritz, Catherine J. Wu, D. DeAngelo, D. Neuberg, R. Stone, R. Soiffer   +32 more
semanticscholar   +1 more source

Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML. [PDF]

Hemasphere
Fiskus W, Mill CP, Piel J, Collins M, Hentemann M, Cuglievan B, Birdwell CE, Das K, Davis JA, Hou H, Jain A, Malovannaya A, Flores LB, Kadia TM, Daver N, Sasaki K, Takahashi K, Hammond D, Wang J, Loghavi S, Su X, DiNardo CD, Delwel R, Bhalla KN.   +23 more
europepmc   +1 more source

The effect of decitabine on human induced pluripotent stem cells (hiPSCs) derived CD34⁺ cells expansion and the megakaryocytes generation and maturation. [PDF]

Am J Stem Cells
Liu Y, Zhang H, Li Y, Zhao C.
europepmc   +1 more source

SEPT9 methylation as a diagnostic and predictive biomarker in the progression of ductal carcinoma in situ to invasive breast cancer. [PDF]

Sci Rep
Guo Y, Zhou X, Xu H, Wang G.
europepmc   +1 more source

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms [PDF]

, 2018
Abboud, Camille N.
core   +1 more source

Decitabine-mediated DNA methylation dynamics at pericentromeric satellite 2 repeats. [PDF]

BMC Cancer
Sordini E, Ciurlia E, Zanella A, Fogliardi B, Lame D, Poloni A, Amatori S, Fanelli M.   +7 more
europepmc   +1 more source

Regulation of major histocompatibility complex class-I (MHC-I) gene methylation using DNA methyltransferase inhibitor and PD-L1 inhibitor in triple negative breast cancer. [PDF]

Discov Oncol
Jeong YJ, Lee NR, Oh HK.
europepmc   +1 more source

Epigenetic Reprogramming by Decitabine in Triple-Negative Breast Cancer: Mechanisms, Immune Modulation, and Therapeutic Synergy. [PDF]

Cancers (Basel)
Riyas Mohamed FR, Aldubaisi S, Akbar A, Khan MI, Yaqinuddin A.   +4 more
europepmc   +1 more source

Decitabine-Driven Foetal Haemoglobin Induction in Townes Mice and Human Erythroblasts. [PDF]

EJHaem
Carol Illa A, Chin DWL, Clark M, Petersen J, Skov S, Glenthøj A, Ley CD.   +6 more
europepmc   +1 more source

A New Targeted Therapy Strategy for Lymphoma. [PDF]

MedComm (2020)
Gale RP.
europepmc   +1 more source